[go: up one dir, main page]

CU22281A1 - Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained. - Google Patents

Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained.

Info

Publication number
CU22281A1
CU22281A1 CU1991105A CU1991105A CU22281A1 CU 22281 A1 CU22281 A1 CU 22281A1 CU 1991105 A CU1991105 A CU 1991105A CU 1991105 A CU1991105 A CU 1991105A CU 22281 A1 CU22281 A1 CU 22281A1
Authority
CU
Cuba
Prior art keywords
vaccine
sup
virus
encephalomiocarditis
procedure
Prior art date
Application number
CU1991105A
Other languages
Spanish (es)
Inventor
Izquierdo Laura E Gomez
Freddy Lorenzo Rocha
Marquez Nancy F Trujillo
Pomares Teresa C Puentes
Stiven Nancy Martinez
Original Assignee
Inst De Medicina Veterinaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Medicina Veterinaria filed Critical Inst De Medicina Veterinaria
Priority to CU1991105A priority Critical patent/CU22281A1/en
Publication of CU22281A1 publication Critical patent/CU22281A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE RELACIONA CON LA RAMA AGROPECUARIA Y LA MEDICINA VETERINARIA. EL PRESERVATIVO TIMEROSAL EN DILUCION 1:10,000-1:100,000. LA VACUNA OBTENIDA POR ESTE PROCEDIMIENTO PUEDE SER APLICADA A OTRAS ESPECIES QUE PADECEN LA ENFERMEDAD. OBJETIVO TECNICO QUE PERSIGUE ES LA OBTENCION DE UNA VACUNA INACTIVADA PARA PROTEGER LA ESPECIE PORCINA DE LA ENFERMEDAD PROVOCADA POR EL VIRUS DE LA ENCEFALOMIOCARDITIS. PARTIENDO DEL VIRUS AISLADO DE UN BROTE DE LA ENFERMEDAD SE REPLICO EL MISMO EN UNA LINEA CELULAR DETERMINADA, OBTENIENDO UN TITULO ENTRE 10<SUP>6</SUP>-10<SUP>9</SUP> DICT50/ML; LAS COLECTAS VIRALES SE INACTIVAN Y SE UTILIZAN COMO ADYUVANTE GEL DE HIDROXIDO DE ALUMINIO EN CONCENTRACIONES ENTRE 30-45% Y GLICERINA ENTRE 5-15% COMO\!IT IS RELATED TO THE AGRICULTURAL BRANCH AND VETERINARY MEDICINE. THE TIMEROSAL CONDOM IN DILUTION 1: 10,000-1: 100,000. THE VACCINE OBTAINED BY THIS PROCEDURE MAY BE APPLIED TO OTHER SPECIES SUFFERING FROM THE DISEASE. TECHNICAL PURPOSE THAT HE IS SEEKING IS TO OBTAIN AN INACTIVATED VACCINE TO PROTECT THE SWINE SPECIES FROM THE DISEASE CAUSED BY THE VIRUS OF ENCEPHALOMIOCARDITIS. STARTING FROM THE VIRUS ISOLATED FROM AN OUTBREAK OF THE DISEASE, I REPLIED THE SAME IN A CERTAIN CELL LINE, OBTAINING A TITLE BETWEEN 10 <SUP> 6 </SUP> -10 <SUP> 9 </SUP> DICT50 / ML; THE VIRAL COLLECTS ARE INACTIVE AND ARE USED AS AN ADJUVANT, ALUMINUM HYDROXIDE GEL IN CONCENTRATIONS BETWEEN 30-45% AND GLYCERIN BETWEEN 5-15% AS \!

CU1991105A 1991-05-23 1991-05-23 Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained. CU22281A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU1991105A CU22281A1 (en) 1991-05-23 1991-05-23 Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1991105A CU22281A1 (en) 1991-05-23 1991-05-23 Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained.

Publications (1)

Publication Number Publication Date
CU22281A1 true CU22281A1 (en) 1995-01-31

Family

ID=5459368

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1991105A CU22281A1 (en) 1991-05-23 1991-05-23 Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained.

Country Status (1)

Country Link
CU (1) CU22281A1 (en)

Similar Documents

Publication Publication Date Title
ES2161656A1 (en) SPECIFIC INSEMINATION ACCORDING TO THE SEX OF MAMMALS, WITH LOW NUMBER OF Sperm Cells
ES2175741T3 (en) NEW DERIVATIVES OF SULFINIC ACID, ITS PREPARATION PROCEDURE AND ITS USE.
ES2152304T3 (en) PROCEDURE FOR THE GROWTH OF VIRUS REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND ITS USE IN VACCINES.
EA199800563A1 (en) ANTAGONISTS OF HORMONE, GROWING GONADOTROPIN
ES465514A1 (en) PROCEDURE FOR OBTAINING GLUCOSAMINE DERIVATIVES.
ES8802273A1 (en) Method for inactivating pathogens in blood products.
ES2052603T3 (en) DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
ES2052759T3 (en) PROCEDURE FOR THE OBTAINING OF CAPSULAR POLYOSIDES OF STAPHYLOCOCCES, APPLICATIONS OF THESE POLIOSIDS AND STRAINS FOR THE IMPLEMENTATION OF THE PROCEDURE.
ES2007720A6 (en) PROCEDURE FOR OBTAINING A VACCINE BASED ON BACTERIAL FLAGEL.
ECSP941082A (en) PROCEDURE FOR THE PREPARATION OF SODIC CRYSTALLINE ADHIDRA SALT OF 5- CHLORINE-3 (2-TENOLI) -2- OXINDOL-1 CARBOXAMIDE
ES2134197T3 (en) VACCINES AGAINST HERPES SIMPLEX VP16 VIRUSES.
GB1161333A (en) Animal Vaccine
SE7512828L (en) CALICIVIRUSVACCIN
CU22281A1 (en) Procedure for obtaining a vaccine against the encephalomiocarditis virus, and the vaccine thus obtained.
ES2196000T3 (en) PIRROLOAZEPINE COMPOUND
ATE4156T1 (en) HARVESTER.
ES388883A1 (en) 1-(2&#39;-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof
ES414955A1 (en) Halogenated 4-(4&#39;-bisphenylyl)-butanols
ES484698A1 (en) Process for the manufacture of sodium amoxicillin preparations.
DK313587D0 (en) TETRAHYDROBENZOTHIAZOL COMPOUNDS, THEIR PREPARATION AND USE
ES2171169T3 (en) USE OF MODIFIED TALL-104 CELLS TO TREAT CANCER AND VIRAL DISEASES.
ES2178760T3 (en) USE OF SODIUM 2-MERCAPTOETHANOSULPHANATE IN SURGERY.
KR840006767A (en) Antifungal Gel Composition
ES446637A1 (en) PROCEDURE FOR THE PREPARATION OF ACELLULAR VACCINES.
ES2151891T3 (en) CICLOHEXAN DERIVATIVES REPLACED WITH IMIDAZOLIL.